All Outputs (5)

Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression (2008)
Journal Article
Kogianni, G., Walker, M. M., Waxman, J., & Sturge, J. (2009). Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. European Journal of Cancer, 45(4), 685-693. https://doi.org/10.1016/j.ejca.2008.11.023

Endo180 (CD280; MRC2; uPARAP) regulates collagen remodelling and chemotactic cell migration through cooperation with membrane type-1 matrix metalloproteinase (MT1-MMP), urokinase-type plasminogen activator receptor (uPAR) and urokinase-type plasminog... Read More about Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression.

The role of endo180 in the development of metastatic prostate cancer bone lesions (2008)
Presentation / Conference Contribution
Kogianni, G., Elefteriou, K., Waxman, . J., Cobb, . J. P., & Sturge, J. (2008, October). The role of endo180 in the development of metastatic prostate cancer bone lesions. Presented at International Conference of Anticancer Research 2008, Kos, Greece

Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression (2008)
Presentation / Conference Contribution
Kogianni, G., Walker, M., Waxman, J., & Sturge, J. Endo180 expression by tumour cells with an invasive phenotype correlates with prostate cancer progression

OC6. Endo180 function in metastatic prostate cancer bone lesions (2008)
Presentation / Conference Contribution
Kogianni, G., Eleftheriou, K., Waxman, J., Cobb, J. P., & Sturge, J. OC6. Endo180 function in metastatic prostate cancer bone lesions. Presented at VII International Conference on Cancer Induced Bone Disease, Edinburgh

Bone cell biology and the pathology of tumor bone metastases (2008)
Digital Artefact
Kogianni, G., & Sturge, J. Bone cell biology and the pathology of tumor bone metastases. [Online review]